Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays

Laryngoscope

Volumn 113, Issue 5, 2003, Pages 808-814

  Tokuriki, Masaharu ^b   Noda, Ichiro ^b   Saito, Takehisa ^a   Narita, Norihiko ^b   Sunaga, Hiroshi ^b   Tsuzuki, Hideaki ^b   Ohtsubo, Toshio ^b   Fujieda, Shigeharu ^b   Saito, Hitoshi ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE

Author keywords

Calgranulins; Cathepsins; Cholesteatoma; Complementary DNA array; Reverse transcriptase polymerase chain reaction

Indexed keywords

CALGRANULIN; CATHEPSIN D; CATHEPSIN H; DIPEPTIDYL PEPTIDASE I; GENE PRODUCT; PSORIASIN; THYMOSIN BETA10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CHOLESTEATOMA; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANTIBODIES; CALCIUM-BINDING PROTEINS; CALGRANULIN A; CALGRANULIN B; CATHEPSIN D; CATHEPSINS; CELL DIFFERENTIATION; CELL MOVEMENT; CHOLESTEATOMA, MIDDLE EAR; CYSTEINE ENDOPEPTIDASES; DIPEPTIDYL PEPTIDASE I; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMOSIN; UP-REGULATION;

EID: 0038642126     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200305000-00008     Document Type: Article

References (42)

1. Bujia J, Holly A, Antoli-Candela F, Tapia MG, Kastenbauer E. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope 1996;106:865-868.
2. Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257-265.
3. Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000;21:793-798.
4. Park HJ, Park K. Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma. Laryngoscope 1999;109:613-616.
5. Kojima H, Miyazaki H, Tanaka Y, Shiwa M, Koga T, Moriyama H. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg 1999;125:738-742.
6. Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 1996;116:451-456.
7. Banerjee AR, James R, Narula AA, Lee RJ. Matrix metalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis. Clin Otolaryngol 1998;23:515-519.
8. Schmidt M, Grunsfelder P, Hoppe F. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts. Eur Arch Otorhinolaryngol 2000;257:425-429.
9. Shibosawa E, Tsutsumi K, Takakuwa T, Takahashi S. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas. Am J Otol 2000;21:621-624.
10. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996;93:10614-10619.
11. Narita N, Noda I, Ohtsubo T, et al. Analysis of heat-shock related gene expression in head and neck cancer using cDNA arrays. Int J Radiat Oncol Biol Phys 2002;53:190-196.
12. Mann B, Gelos M, Siedow A, et al. Target genes of betacatenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999;96:1603-1608.
13. Hipfel R, Garbe C, Schittek B. RNA isolation from human skin tissues for colorimetric differential display. J Biochem Biophys Methods 1998;37:131-135.
14. Schena M, Shalon D, Heller R, et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996;93:10614-10619.
15. Levenson VV, Davidovich IA, Roninson IB. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response. Cancer Res 2000;60:5027-5030.
16. Thacher SM, Nagpal S, Klein ES, et al. Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes. Cell Growth Differ 1999;10:255-262.
17. Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000;67:923-936.
18. Al-Haddad S, Zhang Z, Leygue E, et al. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999;155:2057-2066.
19. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998;83:3925-3929.
20. Fujieda S, Zhang K, Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cells γ subclass-specific isotype switch: switching to γ1, γ3, and γ4, but not γ2. J Immunol 1995;155:2318-2328.
21. Goebeler M, Roth J, van den Bos C, Ader G, Sorg C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem J 1995;309:419-424.
22. Moog-Lutz C, Bouillet P, Regnier CH, et al. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer 1995;63:297-303.
23. Fujioka O, Huang CC. Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1994;251:199-204.
24. Ravdin PM. Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res Treat 1993;24:219-226.
25. Sato K, Waguri S, Ohsawa Y, et al. Immunocytochemical localization of lysosomal cysteine and aspartic proteinases, and ubiquitin in rat epidermis. Arch Histol Cytol 1997;60:275-287.
26. Bankowska A, Gacko M, Chyczewska E, Worowska A. Biological and diagnostic role of cathepsin D. Rocz Akad Med Bialymst 1997;42:79-85.
27. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-1630.
28. Hall AK. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 1991;48:672-677.
29. Holly A, Bujia J, Lempart K, Serge M. Expression of calgranulin A and B in middle ear cholesteatoma [in German]. Laryngorhinootologie 1995;74:33-35.
30. Dallari S, Cavani A, Bergamini G, Girolomoni G. Integrin expression in middle ear cholesteatoma. Acta Otolaryngol 1994;114:188-192.
31. Algermissen B, Sitzmann J, LeMotte P, Czarnetzki B. Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res 1996;288:426-430.
32. Califano D, Monaco C, Santelli G, et al. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res 1998;58:823-828.
33. Santelli G, Califano D, Chiappetta G, et al. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 1999;155:799-804.
34. Viglietto G, Califano D, Bruni P, et al. Regulation of thymosin β10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes. Eur J Endocrinol 1999;140:597-607.
35. Desloge RB, Finstad CL, Sassoon J, Han JC, Parisier SC, Albino AP. Altered regulation of cell surface peptidases in human cholesteatoma. Otolaryngol Head Neck Surg 1997;116:58-63.
36. , Hochstrasser K, Albrecht GJ, Gebhard W, Rasp G, Kastenbauer E. Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma. Eur Arch Otorhinolaryngol 1994;251:30-35.
37. Nakamura M, Yamashiro Y, Nakahodo K, et al. Plasminogen activators in tissue extract of aural cholesteatoma. Laryngoscope 1995;105:305-310.
38. Iwanaga M, Yamamoto E, Fukumoto M. Cathepsin activity in cholesteatoma. Ann Otol Rhinol Laryngol 1985;94:309-312.
39. Garcia M, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990;5:1809-1814.
40. Keyszer GM, Heer AH, Kriegsmann J, et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum 1995;38:976-984.
41. Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol 1996;110:534-539.
42. Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM. Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation. Br J Dermatol 1999;141:453-459.